End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,150 KRW | +1.07% | +16.32% | +43.82% |
Business Summary
Number of employees: 54
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical
52.9
%
| 2,737 | 54.1 % | 2,617 | 52.9 % | -4.39% |
New Drug
26.0
%
| - | - | 1,287 | 26.0 % | - |
Food
15.2
%
| 802 | 15.8 % | 751 | 15.2 % | -6.26% |
Functional Materials
6.0
%
| - | - | 295 | 6.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.6
%
| 5,060 | 100.0 % | 4,930 | 99.6 % | -2.58% |
Overseas
0.4
%
| 2 | 0.0 % | 21 | 0.4 % | +809.19% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tae-Young Yun
CEO | Chief Executive Officer | 61 | - |
Jeong-Keun Kim
CEO | Chief Executive Officer | 64 | 98-12-07 |
Yoon-Tae Kim
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Sang-Hyeon Lee
BRD | Director/Board Member | 51 | 99-08-31 |
Chang-Nam Kim
AUD | Comptroller/Controller/Auditor | 64 | 09-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeong-Keun Kim
CEO | Chief Executive Officer | 64 | 98-12-07 |
Sang-Hyeon Lee
BRD | Director/Board Member | 51 | 99-08-31 |
Tae-Young Yun
CEO | Chief Executive Officer | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,993,965 | 33,075,965 ( 87.06 %) | 0 | 86.61 % |
Stock B | 0 | 193,423 | 0 | 0 |
Company contact information
Oscotec, Inc.
9/F, Building A, Korea Bio Park 700 Daewangpangyo-ro
13488, Seongnam-si
+
http://www.oscotec.comSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.82% | 931M | |
+14.89% | 78.65B | |
+9.32% | 8.94B | |
-10.76% | 5.16B | |
+54.31% | 4.85B | |
+11.19% | 4.19B | |
-22.37% | 2.32B | |
+11.72% | 2.29B | |
-30.09% | 2.19B | |
+20.63% | 2.19B |
- Stock Market
- Equities
- A039200 Stock
- Company Oscotec Inc.